R. Müller
Pharmaceutical Companies
NeoClone
Turkey
Biography
"Prior to joining Neoclone, Dr. Müller was VP for Applied Science at Nanosphere (Northbrook, IL), where he led the research and early development of genomic microarray-based SNP assays, as well as nanoparticle-based high-sensitivity assays for protein detection. Before joining Nanosphere, Dr. Müller held the position of Technology Director at Corning, Inc., where he developed and led the Biochemistry Research Department with responsibility for the company's global research activities in the Life Sciences. Prior to joining Corning, Dr. Müller was Director of Advanced Technology at Vysis, Inc. (now Abbott), where his research activities focused on DNA based diagnostics, including DNA probes for fluorescent in situ hybridization and the development of array based assay systems for genomic and expression analysis. Dr. Müller received his B.S. degree in Biology from Justus-Liebig Universität, Germany, and his MS and PhD degrees in Microbiology from Kansas State University, Manhattan, KS. After a postdoc in Biochemistry (University of Wisconsin, Madison) he became an Assistant and then tenured Associate Professor in the Department of Microbiology and Immunology at East Carolina University School of Medicine (Greenville, NC)."
Research Interest
His research interests include fields like Proteins